SCHEMBL60431

SCHEMBL60431

O=CCCC(=O)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL665744 1.00 OR51E2 (0.55)
Alpha-Ketoglutaric Acid SCHEMBL12760653 0.87 EGLN1 (0.70)
SCHEMBL1296671 0.83 OR51E2 (0.50)
SCHEMBL14386822 0.81 MAPK1 (0.48)
SCHEMBL23174677 0.79 MAPK1 (0.46)
SCHEMBL28777797 0.79 MAPK1 (0.46)
SCHEMBL21600769 0.79 MAPK1 (0.46)
SCHEMBL11678127 0.79 MAPK1 (0.46)
Benzene SCHEMBL8775366 0.79 OR51E2 (0.46)
SCHEMBL7939722 0.79 HIF1A (0.37)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 280 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117500802-A LACTIVICIN compounds, their preparation and their use as antibacterial agents 费多拉制药有限公司 2024-02-02 CN claimed
EP-4056706-A1 MICROORGANISMS FOR THE PRODUCTION OF 1,4-BUTANEDIOL AND RELATED METHODS Genomatica, Inc. (US) 2022-09-14 EP claimed
US-11401534-B2 Microorganisms for the production of 1,4- butanediol and related methods GENOMATICA, INC. (US) 2022-08-02 US claimed
WO-2021062048-A2 METHODS AND SYSTEMS FOR MODULATING HEPATIC GABA PRODUCTION OR RELEASE TO ALTER FOOD INTAKE IN MONOGASTRIC SPECIES ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) 2021-04-01 WO claimed
US-9909129-B2 Biosynthetic pathways and methods REGENTS OF THE UNIVERSITY OF MINNESOTA (US) 2018-03-06 US claimed
WO-2018005770-A2 SYNTHETIC CARBON FIXATION PATHWAYS Invista North America S.á.r.l. (US) 2018-01-04 WO claimed
US-20170137855-A1 RECOMBINANT CELLS AND METHODS FOR NONPHOSPHORYLATIVE METABOLISM REGENTS OF THE UNIVERSITY OF MINNESOTA 2017-05-18 US claimed
US-20150337342-A1 BIOSYNTHETIC PATHWAYS AND METHODS REGENTS OF THE UNIVERSITY OF MINNESOTA 2015-11-26 US claimed
WO-2014100173-A1 BIOSYNTHETIC PATHWAYS AND METHODS REGENTS OF THE UNIVERSITY OF MINNESOTA (US) 2014-06-26 WO claimed
US-20140171683-A1 PROCESS FOR THE ENZYMATIC PRODUCTION OF C4 COMPOUNDS FROM C6 SUBSTRATES SIEBER VOLKER (DE) 2014-06-19 US claimed
EP-2689021-A1 PROCESS FOR THE ENZYMATIC PRODUCTION OF C4 COMPOUNDS FROM C6 SUBSTRATES Sieber, Volker (DE) 2014-01-29 EP claimed
WO-2012127057-A1 PROCESS FOR THE ENZYMATIC PRODUCTION OF C4 COMPOUNDS FROM C6 SUBSTRATES SIEBER VOLKER (DE) 2012-09-27 WO claimed
EP-2503003-A1 Synthetic pathway for the production of alcohols or amines Sieber, Volker (DE) 2012-09-26 EP claimed
US-20250376656-A1 MASSIVELY PARALLEL ON-CHIP CONSTRUCTION OF SYNTHETIC MICROBIAL COMMUNITIES MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2025-12-11 US disclosed
US-20250361531-A1 MICROORGANISMS AND METHODS FOR PRODUCTION OF 4-HYDROXYBUTYRATE, 1,4-BUTANEDIOL AND RELATED COMPOUNDS AGAIN BIO APS (DK) 2025-11-27 US disclosed
US-20250258146-A1 QUANTITATIVE DETECTION METHOD OF MULTIPLE METABOLITES IN BIOLOGICAL SAMPLE AND METABOLIC CHIP HUMAN METABOLOMICS INSTITUTE INC. (CN) 2025-08-14 US disclosed
WO-2001038347-A2 PEPTIDES HAVING ANTIANGIOGENIC ACTIVITY ABBOTT LABORATORIES (US) 2001-05-31 WO disclosed
EP-1078002-A1 PEPTIDE ANTIANGIOGENIC DRUGS ABBOTT LABORATORIES (US) 2001-02-28 EP disclosed
WO-1999061476-A1 PEPTIDE ANTIANGIOGENIC DRUGS ABBOTT LABORATORIES (US) 1999-12-02 WO disclosed
CN-1216460-A Oxa diacids and related compounds for treating skin conditions AVON PROD INC (US) 1999-05-12 CN disclosed